Article Versions Notes

Du T-Q, Liu R, Zhang Q, Luo H, Liu Z, Sun S, Wang X. EZH2 as a Prognostic Factor and Its Immune Implication with Molecular Characterization in Prostate Cancer: An Integrated Multi-Omics in Silico Analysis. Biomolecules. 2022; 12(11):1617. https://doi.org/10.3390/biom12111617

Du, Tian-Qi, Ruifeng Liu, Qiuning Zhang, Hongtao Luo, Zhiqiang Liu, Shilong Sun, and Xiaohu Wang. 2022. "EZH2 as a Prognostic Factor and Its Immune Implication with Molecular Characterization in Prostate Cancer: An Integrated Multi-Omics in Silico Analysis" Biomolecules 12, no. 11: 1617. https://doi.org/10.3390/biom12111617

Du, T.-Q., Liu, R., Zhang, Q., Luo, H., Liu, Z., Sun, S., & Wang, X. (2022). EZH2 as a Prognostic Factor and Its Immune Implication with Molecular Characterization in Prostate Cancer: An Integrated Multi-Omics in Silico Analysis. Biomolecules, 12(11), 1617. https://doi.org/10.3390/biom12111617